Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial which tested the drug Herceptin and delivered a major breakthrough for women with HER2-positive breast cancer.In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Find out more: www.breastcancertrials.org.au

Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial which tested the drug Herceptin and delivered a major breakthrough for women with HER2-positive breast cancer. In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Find out more: www.breastcancertrials.org.au

When a Drug Shows Promise: What Happens Next in Clinical Trials?

Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand, with a commitment to exploring and finding better treatments for people affected by breast cancer through clinical trials research. The Breast Cancer Trials Podcast is a platform to share the latest in breast cancer research, to share stories and experiences of those who have had breast cancer, and to help explain topics around breast cancer and clinical trials research. www.breastcancertrials.org.au

Share When a Drug Shows Promise: What Happens Next in Clinical Trials?

Sign up to save your podcasts

When a Drug Shows Promise: What Happens Next in Clinical Trials?

When a Drug Shows Promise: What Happens Next in Clinical Trials?